ciprofloxacin has been researched along with clindamycin in 231 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (3.90) | 18.7374 |
1990's | 50 (21.65) | 18.2507 |
2000's | 73 (31.60) | 29.6817 |
2010's | 79 (34.20) | 24.3611 |
2020's | 20 (8.66) | 2.80 |
Authors | Studies |
---|---|
Borodkin, S; Chu, DT; Fernandes, PB; Lico, IM; Pernet, AG; Rosen, T; Shen, L | 1 |
Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
Adams, DA; Donskey, CJ; Riggs, MM | 1 |
Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Dahl, EL; Rosenthal, PJ | 1 |
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Castanheira, M; Deshpande, LM; DiPersio, J; Jones, RN; Mendes, RE; Saubolle, MA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Chen, H; Chen, M; Du, N; Liu, Y; Niu, J; Shen, E; Wang, H; Ye, H | 1 |
Langsley, G; Lizundia, R; Ralph, SA; Werling, D | 1 |
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
Espinal, P; Gibert, I; Marti, S; Martínez, P; Roca, I; Vila, J | 1 |
Ekambaram, R; Raghunathan, M; Raghunathan, R; Rao, SS | 1 |
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
Mima, T; Schweizer, HP | 1 |
Dai, L; Huang, SY; Li, BB; Shen, JZ; Wang, MG; Wang, Y; Wu, CM; Xia, LN | 1 |
Barrow, EW; Barrow, WW; Berlin, KD; Bourne, CR; Bourne, PC; Bunce, RA | 1 |
Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
Basset, P; Blanc, DS; Senn, L; Vogel, V; Zanetti, G | 1 |
Crandon, JL; Kuti, JL; Nicolau, DP | 1 |
Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Steenbergen, J; Tanaka, SK; Villano, S | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
Abutaleb, NS; Aryal, UK; Dieterly, A; Eldesouky, HE; Karanja, C; Liang, HW; Lyle, T; Naclerio, GA; Onyedibe, KI; Seleem, MN; Sintim, HO | 1 |
Benada, O; Bogdanová, K; Dávidová, E; Do Pham, DD; Fišer, R; Galandáková, A; Helusová, M; Kolář, M; Krásný, L; Křížek, T; Mikušová, G; Mojr, V; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedláková, MH; Sudzinová, P; Večeřová, R; Vítovská, D | 1 |
Avanessian, AB; Lomeli, SL; Nachnani, S; Newman, MG; Scuteri, A | 1 |
Verbist, L; Verhaegen, J | 1 |
Lenz, W; Machka, K; Milatovic, D; Voss, A | 1 |
Monif, GR; Osborne, NG | 1 |
Adams, K; Calhoun, J; Cierny, G; Couch, L; Mader, JT | 1 |
Baker, CN | 1 |
Goodwin, SD; Heyd, A; Nix, DE; Wilton, JH | 1 |
Deeter, RG; Gross, JS; Swanson, KA; Weinstein, MP | 1 |
Faro, S; Hammill, HA; Maccato, ML; Martens, MG | 1 |
Bansal, MB; Mathai, D; Savage, E; Scotti, R; Thadepalli, H | 1 |
Cassell, GH; Crabb, D; Duffy, LB; Pate, MS; Schmid, T; Waites, KB | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
O'Keefe, E; Paszko, A; Sesin, GP | 1 |
Calhoun, J; Cantrell, JS; Mader, JT | 1 |
Baxter, R; Chapman, J; Drew, WL | 1 |
Crombleholme, WR; Luft, J; Ohm-Smith, M; Schachter, J; Sweet, RL; Whidden, R | 1 |
Apuzzio, JJ; Ganesh, V; Jain, S; Kaminski, Z; Louria, D; Stankiewicz, R | 1 |
Boeckh, M; Borner, K; Deppermann, KM; Grineisen, S; Koeppe, P; Krasemann, C; Lode, H; Shokry, F; Wagner, J | 1 |
Lahnborg, G; Nord, CE | 1 |
Traub, WH | 1 |
Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B | 1 |
Meier-Ewert, H; Steele-Mortimer, O | 1 |
Esposito, S; Gupta, A; Thadepalli, H | 1 |
Byron, MP; Carruth, WA; Hampton, AA; Sherertz, RJ; Solomon, DD | 1 |
Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
Armengol, S; Moreno, JA; Tomás, R; Torrabadella, P; Xirgu, J | 1 |
Ohl, CA; Paparello, S; Sullivan, N | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
Bassaris, HP; Dougenis, D; Gogos, CA; Skoutelis, AT | 1 |
Oz, HS; Retsema, J; Tanowitz, HB; Wasserman, S; Weiss, LM; Wittner, M | 1 |
Auckenthaler, R; Peyret, M; Rohner, P | 1 |
Grøndahl, TO; Langmoen, IA | 1 |
Benjamin, RS; Escalante, C; Fender, A; Hughes, P; Kennedy, K; Loewy, J; Manzullo, E; Moreland, B; Rolston, K; Rubenstein, EB | 1 |
Blecker, DL; Ferraro, AL; Mortensen, JE; Phengvath, C | 1 |
Cohen, RO; Colodner, R; Keness, J; Ziv, G | 1 |
Franz, A; Furr, PM; Hughes, GR; Steuer, A; Taylor-Robinson, D; Webster, AD | 1 |
Ayers, LW; Barnishan, J; Fass, RJ | 1 |
Hecht, DW; Osmolski, JR | 1 |
Alric, L; Bonnet, E; Bonnet, M; Goldzack, M; Massip, P | 1 |
Garcia, R; Raad, I | 1 |
Arredondo, JL; Diaz, V; Gaitan, H; Maradiegue, E; Oyarzún, E; Paz, R; Reynal, JL; Stamm, W; Zambrano, D | 1 |
Maskell, JP; Rafay, AM; Sefton, AM; Whiley, A; Williams, JD | 1 |
Dofferhoff, AS; Janssen, AJ; van de Leur, JJ; Vollaard, EJ | 1 |
Cohen, MA; Huband, MD | 1 |
Falagas, ME; McDermott, L; Snydman, DR | 1 |
Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
Fichera, ME; Roos, DS | 1 |
Goumas, PD; Moschovakis, ED; Naxakis, SS; Papavasiliou, DA; Skoutelis, A; Tsintsos, SJ | 1 |
Baiocchi, P; Carfagna, P; Cassone, M; Galiè, M; Santini, C; Tarasi, D; Venditti, M | 1 |
Hof, H; Kretschmar, M; Laufen, H; Meyer, A; Nichterlein, T; Schadt, A; Wildfeuer, A | 1 |
Bolgos, G; Green, L; Newcomb, D; Remick, DG | 1 |
Diamantopoulos, EJ; Grigoriadou, M; Haritos, D; Margariti, G; Paniara, O; Raptis, SA; Yfandi, G | 1 |
Peters, G; Schumacher-Perdreau, F | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Lüke, C; Sickel, W; Walter, P | 1 |
Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
Alarcón, T; Jiménez, ML; Limia, A; López-Brea, M | 1 |
Dominik, J; Hejzlar, M; Kubícek, J; Lonská, V; Lonský, V; Mand'ák, J; Marsíková, M; Pozlerová, E; Snítilová, M | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Benedetti, P; de Lalla, F; Du Jardin, G; Erle, G; Fabris, P; Lora, L; Martini, Z; Pellizzer, G; Strazzabosco, M | 1 |
Abu El-Asrar, AA; Kadry, AA; Shibl, AM; Tawfik, AF | 1 |
Benedetti, P; Bonato, M; de Lalla, F; Erle, G; Furlan, F; Lora, L; Pellizzer, G; Presi, S; Strazzabosco, M | 1 |
Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
Berman, EL; Bersoff-Matcha, S; Cerva, D; Druckenbrod, G; Earls, J; Fatteh, N; Hanfling, D; Harper, S; Mayer, TA; Murphy, C; Napoli, A; Nayyar, A; Nguyen, M; Pauze, D; Rosenthal, J | 1 |
Brown, K | 1 |
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
Harada, T; Ito, Y; Iwai, S; Iwanaga, H; Kato, K; Nakagawa, Y; Sato, T; Takayama, T | 1 |
Abdlslam, K; Gibson, RJ; Thumbikat, P | 1 |
Behra-Miellet, J; Dubreuil, L; Jumas-Bilak, E | 1 |
Allianatos, PG; Koutsoukou, AD; Tilentzoglou, AC | 1 |
Hörnlein, B; Irsigler, K; Kästenbauer, T; Sokol, G | 1 |
Hiramatsu, K; Hirata, N; Kadota, J; Nasu, M | 1 |
Ferreira, MC; Teng, HW; Zumiotti, AV | 1 |
Eisenblätter, M; Hahn, H; Ignatius, R; Jabbusch, M; Wagner, J; Wendt, C | 1 |
Aktaş, E; Ayyildiz, A; Ertek, M; Parlak, M; Yazgi, H | 1 |
Amâncio, RT; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; David, CM; Gomes, RN; Vianna, RC | 1 |
Choo, CM; Lim, T; Lim, YS; Ngan, CC; Toh, GL | 1 |
Böhringer, R; Krautmacher, C; Vetter, H; Weisser, B | 1 |
Cernohorská, L; Votava, M | 1 |
Badrina, N; Benjamin, R; DeJesus, Y; Escalante, CP; Fernandez, S; Ho, V; Lam, T; Lee, EL; Manzullo, E; Rivera, E; Rolston, K; Valdres, R; Weiser, MA | 1 |
Cieślikowski, T; Nowak, T; Rózalska, M; Szewczyk, EM | 1 |
Arslan, A; Basa, S; Metin, M; Sayan, MA; Sayar, A | 1 |
Bierschneider, M; Boszczyk, BM; Jaksche, H; Robert, B; Schmid, KE; Zarfl, A | 1 |
Bolduc, DL; Brook, I; Camp-Hyde, TD; Elliott, TB; Foriska, MA; Germana, A; Giraldo, DE; Jackson, WE; Ledney, GD; Shoemaker, MO; Thakar, JH | 1 |
Aga, DS; Batt, AL; Bruce, IB | 1 |
Barry, C; Choo, M; Morris, P; O'Sullivan, E; Thompson, CJ | 1 |
Caniça, M; Dias, R; Louro, D | 1 |
Li, JT; Markus, P; Matesic, D; Park, M | 1 |
Goodman, CD; McFadden, GI; Su, V | 1 |
Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J | 1 |
Haggerty, CL; Ness, RB | 1 |
Guss, J; Kazahaya, K | 1 |
Dargatz, DA; Englen, MD; Fedorka-Cray, PJ; Hill, AE; Ladely, SR | 1 |
David, S; Ekkernkamp, A; Frank, M; Matthes, G; Schmucker, U; Seifert, J | 1 |
Putcharoen, O; Suankratay, C | 1 |
Ito, K; Izumi, K; Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K | 1 |
Ataullah, S; Cannon, PS; Leatherbarrow, B; Mc Keag, D; Radford, R | 1 |
Honda, E; Lima, AL; Rudelli, S; Uip, D | 1 |
Bingen, E | 1 |
Cao, JP; Chen, SX; Jiang, XG; Wu, L | 1 |
Chang, CL; Choi, GE; Kang, JE; Kim, JM; Kim, KH; Lee, EY; Tateda, K; Yamaguchi, K | 1 |
Chou, CH; Hsu, HL; Hsueh, PR; Huang, YT; Lai, CC; Liao, CH; Tan, CK | 1 |
Arslan, O; Kockar, F; Sinan, S; Yildirim, H | 1 |
Fajardo, M; Garduno, E; Hidalgo, R; Robles, M; Rodríguez, FF; Rodríguez, S | 1 |
Banaszkiewicz, A; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; Wultańska, D | 1 |
Fusté, E; Veiga-Crespo, P; Villa, TG; Viñas, M; Vinuesa, T | 1 |
Jeon, B; Qin, SS; Shen, JZ; Shen, ZQ; Wang, Y; Wu, CM; Zhang, Q | 1 |
Fanning, KJ; Prins, JB; Roberts, MS; Robertson, TA | 1 |
Lapid, O | 1 |
Hoseini, MG; Masdari, Z; Shirazi, MR; Yazdi, HR | 1 |
Cui, X; Eichacker, PQ; Hicks, CW; Li, Y; Sweeney, DA | 1 |
Fakhr, MK; Noormohamed, A | 1 |
Andersen, LP; Berg, D; Jonaitis, L; Jørgensen, M; Kadusevicius, E; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Miciuleviciene, J; Rasmussen, L; Tamosiunas, V; Urbonaviciene, N | 1 |
Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 2 |
Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B | 1 |
Degener, JE; Rams, TE; van Winkelhoff, AJ | 2 |
Isaacs, J; Pullan, RD; Whelan-Johnson, S | 1 |
Becerro-de-Bengoa-Vallejo, R; Losa-Iglesias, ME | 1 |
Krivda, S; Norton, SA; Pace, S; Steigelman, D | 1 |
Mansouri, S; Sadeghi, J | 1 |
Gounari, P; Kougias, M; Sioula, E; Skourtis, A; Vallianou, N | 1 |
de Vries, MG; Ekkelenkamp, MB; Peters, EJ | 1 |
Bernatová, S; Dvořáčková, M; Holá, V; Jákl, P; Ježek, J; Krzyžánek, V; Pilát, Z; Růžička, F; Samek, O; Serý, M; Siler, M; Zemánek, P | 1 |
Klein, EY; Laxminarayan, R; May, L; Rothman, RE | 1 |
Drew, RJ; Paulus, S | 1 |
Al-Ahmad, A; Ameen, H; Anderson, AC; Hellwig, E; Karygianni, L; Pelz, K; Spitzmüller, B; Wittmer, A | 1 |
Hammert, WC; Richardson, WL | 1 |
Frimodt-Møller, N; Hertz, FB; Løbner-Olesen, A | 1 |
Lamb, B; Patel, K; Pathak, S; Peters, J | 1 |
Büchler, AC; Ledergerber, B; Peter, S; Rampini, SK; Ruef, C; Schweiger, A; Speck, RF; Stelling, S; Zbinden, R | 1 |
Nord, CE; Rashid, MU; Weintraub, A | 1 |
Ehrlich, Y; Platt, JA; Prather, BT; Spolnik, K; Yassen, GH | 1 |
Ankirskaya, AS; Lubasovskaya, LA; Melkumyan, AR; Murav'eva, VV; Priputnevich, TV | 1 |
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S | 1 |
Buijs, MJ; Crielaard, W; Keijser, BJ; Nord, CE; Rashid, MU; Weintraub, A; Zaura, E | 1 |
Anjum, MF; Card, RM; Hunt, T; Kirchner, M; Mafura, M; Nord, CE; Rashid, MU; Weile, J; Weintraub, A | 1 |
Dermota, U; Grmek-Košnik, I; Janežič, S; Mueller-Premru, M; Petrovič, Ž; Ribič, H; Rupnik, M; Švent-Kučina, N; Zdovc, I | 1 |
Armitage, C; Babey, K; Brintnell, WC; Dickins, T; Kelly, L; Kelton, S; Milne, WK; Muileboom, J; Voth, B | 1 |
Hamad, T; Hellmark, B; Nilsdotter-Augustinsson, Å; Söderquist, B | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Ammenouche, N; Castelain, S; Choquet, M; Decroix, V; Guiheneuf, R; Pluquet, E | 1 |
Azarkar, Z; Bidaki, MZ | 1 |
Akcaer, M; Coskun, O; Karakas, A; Sari, S; Tok, D | 1 |
Gallert, C; Heß, S | 1 |
Cavallaro, MC; Chehter, N; Del Nero, LG; Marta, GN; Zambon, LS | 1 |
Beall, B; Chochua, S; Gertz, RE; Glennen, A; Hawkins, PA; Li, Y; Li, Z; Lynfield, R; McGee, L; Metcalf, BJ; Tran, T; Walker, H | 1 |
Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
Lee, JS; Pan, JY; Tan, M | 1 |
Jia, H; Li, B; Li, Y; Liu, K; Ma, L; Ma, Z; Qiu, Y; Shao, D; Shi, Y; Wei, J | 1 |
Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R | 1 |
Cui, L; Liu, C; Liu, G; Sun, P; Tang, C; Xia, W; Xie, L; Xu, Y | 1 |
Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
Bayston, R; Belfield, K; Birchall, JP; Daniel, M; Hajduk, N; Levell, G | 1 |
Chen, CJ; Chuang, YY; Huang, YC; Ko, WC; Lauderdale, TY; Lee, CY; Lu, CT; Lu, MC; Wu, TS; Yang, CC | 1 |
Bottino, MC; Feitosa, SA; Gregory, RL; Hamer, EI; Karczewski, A; Pankajakshan, D; Spolnik, KJ | 1 |
Assfoura, L; Mansour, O; Raslan, N | 1 |
Bar-David, E; Ben-Shmuel, A; Brosh, T; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Guimbellot, JS; Poore, TS; Virella-Lowell, I | 1 |
Balakrishnan, V; I, K; Kumar, RA; Narayan, GS; Neelamurthy, PS; Venkatesan, SM | 1 |
Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
Alksne, L; Avsejenko, J; Bērziņš, A; Cibrovska, A; Eglīte, L; Grantiņa-Ieviņa, L; Ķibilds, J; Makarova, S; Meistere, I; Streikiša, M | 1 |
Cornelissen, JJBWJ; de Boer, P; Jurburg, SD; Rebel, JMJ; Smits, MA | 1 |
Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
Brubaker, DK; Griffith, LG; Kester, JC; Lauffenburger, DA; Velazquez, J; Wright, C | 1 |
Barr, JR; Boyer, AE; Chabot, DJ; Cote, CK; Fetterer, DP; Friedlander, AM; Ingavale, S; Klimko, CP; Miller, JA; Schellhase, CW; Somerville, BC; Tobery, SA; Twenhafel, NA; Vietri, NJ; Woolfitt, AR; Wright, ME | 1 |
Buszewski, B; Król-Górniak, A; Pauter, K; Pomastowski, P; Szultka-Młyńska, M; Szumski, M | 1 |
Cooksley, CM; Feizi, S; Nepal, R; Psaltis, AJ; Vreugde, S; Wormald, PJ | 1 |
Hayashi, N; Hirai, Y; Koizumi, J; Nakaminami, H; Nakase, K; Nasu, Y | 1 |
Barak Levitt, J; Barmatz, S; Dalal, A; Fisch-Gilad, S; Hackett, A; Hodak, E; Kremer, N; Levi, A; Pavlovsky, L; Sherman, S; Taieb, Y; Yahav, D | 1 |
Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T | 1 |
Abidi, SH; Ahmed, K; Ali, SN; Khan, S; Mastoor, S; Nazim, F; Rizwan-Ul-Hasan, S | 1 |
Bezzegh, A; Gyarmati, B; Tordé, Á; Tóth, Z; Vásárhelyi, B | 1 |
Ding, L; Hu, F; Liu, Y; Shi, Q; Song, P; Wang, Q; Wu, S; Xu, J; Zhang, J; Zhang, L; Zhang, Q; Zhu, X | 1 |
Attin, T; Bensland, S; Eick, S; Karygianni, L; Kulik, EM; Thurnheer, T | 1 |
Alorabi, M; Ejaz, U; Khoso, BK; Mahmoud, SF; Sohail, M; Uddin, F; Youssef, M | 1 |
Brüggemann, RJM; Gompelman, M; Jager, NGL; Korzilius, JW; Rovers, CP; Wanten, GJA; Wezendonk, GTJ | 1 |
Beschorner, U; Böhme, T; Kramer, TS; Noory, E; Salm, J; Westermann, D; Zeller, T | 1 |
9 review(s) available for ciprofloxacin and clindamycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines | 2016 |
[New effects of antimicrobial agents other than antimicrobial activity].
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Bacteria; Biofilms; Ciprofloxacin; Clindamycin; Cytokines; Depression, Chemical; Drug Interactions; GABA Agonists; Humans; Shock, Septic; Virulence Factors | 2003 |
[Actinomycosis].
Topics: Actinomycosis, Cervicofacial; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Clindamycin; Gentamicins; Humans; Male; Prognosis; Recurrence; Time Factors; Tomography, X-Ray Computed | 2004 |
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
An overview of anthrax infection including the recently identified form of disease in injection drug users.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxacin; Clindamycin; Doxycycline; Humans; Penicillins; Substance Abuse, Intravenous | 2012 |
Adverse effects of common oral antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Ciprofloxacin; Clindamycin; Hand; Hand Dermatoses; Humans; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Incidence; Male; Microbial Sensitivity Tests | 2016 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
18 trial(s) available for ciprofloxacin and clindamycin
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
Ciprofloxacin versus gentamicin/clindamycin for postpartum endometritis.
Topics: Adolescent; Adult; Bacterial Infections; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Infusions, Intravenous; Puerperal Infection | 1991 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Acute Disease; Adolescent; Adult; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Prospective Studies | 1991 |
Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin.
Topics: Acute Disease; Adult; Bacteria; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Microbial Sensitivity Tests; Pelvic Inflammatory Disease | 1989 |
Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection.
Topics: Acute Disease; Adult; Bacterial Infections; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Prospective Studies; Random Allocation; Salpingitis | 1989 |
Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers.
Topics: Adult; Bacteria; Ciprofloxacin; Clindamycin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metronidazole | 1989 |
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Aztreonam; Bacteremia; Bacterial Infections; Ciprofloxacin; Clindamycin; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 1993 |
Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients.
Topics: Administration, Oral; Adult; Ceftriaxone; Ciprofloxacin; Clindamycin; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Laparoscopy; Pelvic Inflammatory Disease | 1997 |
Management and outcome of severe diabetic foot infections.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Blood Glucose; Ciprofloxacin; Clindamycin; Diabetic Foot; Female; Humans; Leg; Male; Microbial Sensitivity Tests; Middle Aged; Regional Blood Flow; Treatment Outcome; Wound Healing | 1998 |
Changes of the serum antibiotic levels during open heart surgery (ceftazidim, ciprofloxacin, clindamycin).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Ceftazidime; Cephalosporins; Ciprofloxacin; Clindamycin; Coronary Artery Bypass; Humans; Prospective Studies | 2000 |
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.
Topics: Adjuvants, Immunologic; Adult; Aged; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Diabetes Complications; Drug Therapy, Combination; Female; Foot; Foot Diseases; Foot Ulcer; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Male; Middle Aged; Osteomyelitis; Recombinant Proteins; Treatment Outcome | 2001 |
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.
Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Drug Therapy, Combination; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Staphylococcus | 2001 |
Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bed Rest; Cellulitis; Ciprofloxacin; Clindamycin; Diabetic Foot; Drug Therapy, Combination; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infections; Injections, Intravenous; Male; Middle Aged; Recombinant Proteins; Treatment Outcome | 2003 |
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ampicillin; Anti-Bacterial Agents; Cancer Care Facilities; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clindamycin; Critical Pathways; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2004 |
[Effectiveness of switch therapy for peritonitis].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Health Care Costs; Humans; Injections, Intravenous; Meropenem; Middle Aged; Naphthyridines; Ofloxacin; Oxazines; Peritonitis; Thienamycins | 2007 |
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Evaluation of antibiotic mix in Non-instrumentation Endodontic Treatment of necrotic primary molars.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clindamycin; Dental Pulp Necrosis; Drug Combinations; Female; Humans; Male; Metronidazole; Minocycline; Molar; Reproducibility of Results; Root Canal Filling Materials; Root Resorption; Tooth, Deciduous; Treatment Outcome | 2017 |
204 other study(ies) available for ciprofloxacin and clindamycin
Article | Year |
---|---|
Asymmetric synthesis and properties of the enantiomers of the antibacterial agent 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-1,4-dihydro-6- fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Solubility; Stereoisomerism; Structure-Activity Relationship | 1988 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
Topics: Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Toxins; Cecum; Clostridioides difficile; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Mice; Microbial Sensitivity Tests | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors | 2008 |
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
Topics: Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections | 2009 |
Theileria apicoplast as a target for chemotherapy.
Topics: Animals; Antiprotozoal Agents; Cattle; Drug Delivery Systems; Inhibitory Concentration 50; Models, Biological; Plastids; Theileria; Theileriasis | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol Resistance; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Tetracyclines | 2009 |
In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycoplasma hominis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolines | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
Topics: Animals; Anti-Bacterial Agents; Bacillus; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Feces; Lincosamides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Streptogramin B; Swine | 2010 |
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Microbial Sensitivity Tests; Protein Structure, Secondary; Protein Structure, Tertiary; Staphylococcus aureus; Tetrahydrofolate Dehydrogenase | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
Topics: Chromosomes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction | 2010 |
Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Staphylococcal Infections; Vancomycin | 2010 |
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2012 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Mechanistic Studies and
Topics: Animals; Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Oxadiazoles; Staphylococcal Infections; Staphylococcus aureus | 2022 |
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
Topics: Albumins; Anti-Bacterial Agents; Cell Membrane; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship | 2022 |
E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteroides; Bacteroides fragilis; Campylobacter; Capnocytophaga; Cefoxitin; Ciprofloxacin; Clindamycin; Clostridium perfringens; Dental Plaque; Eikenella corrodens; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptostreptococcus; Periodontal Diseases; Periodontitis; Porphyromonas gingivalis; Tetracycline | 1992 |
Comparative in-vitro activity of RP 59500.
Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin | 1992 |
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
Topics: Bacterial Infections; Ciprofloxacin; Clindamycin; Female; Gentamicins; Humans; Pelvic Inflammatory Disease | 1992 |
In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Cefazolin; Ciprofloxacin; Clindamycin; Diffusion; Dogs; Granulation Tissue; Methylmethacrylates; Ticarcillin; Tobramycin; Vancomycin | 1992 |
The E-Test and Campylobacter jejuni.
Topics: Anti-Bacterial Agents; Campylobacter jejuni; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Drug Therapy, Combination; Gentamicins; Metronidazole; Solutions; Theophylline; Tobramycin | 1991 |
Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.
Topics: Aged; Ciprofloxacin; Clindamycin; Drug Interactions; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Rifampin; Serum Bactericidal Test | 1991 |
In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Topics: Anti-Infective Agents; Ciprofloxacin; Clindamycin; Culture Media; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Tetracycline; Ureaplasma | 1991 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoperazone; Ciprofloxacin; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Female; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Prevotella melaninogenica; Rabbits; Sulbactam | 1990 |
Oral clindamycin and ciprofloxacin therapy for diabetic foot infections.
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Clindamycin; Diabetes Complications; Drug Therapy, Combination; Foot Diseases; Humans; Length of Stay; Skin Ulcer | 1990 |
Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intravenous; Male; Middle Aged; Nafcillin; Osteomyelitis | 1990 |
Comparison of bactericidal activity of five antibiotics against Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Dicloxacillin; Female; Humans; Male; Middle Aged; Serum Bactericidal Test; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Effect of ciprofloxacin compared to gentamicin in the treatment of experimental intraabdominal infections in rats.
Topics: Abdomen; Abscess; Animals; Bacterial Infections; Ciprofloxacin; Clindamycin; Drug Combinations; Gentamicins; Male; Microbial Sensitivity Tests; Peritonitis; Rats; Rats, Inbred Strains; Surgical Wound Infection | 1989 |
Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.
Topics: Animals; Ciprofloxacin; Clindamycin; Clostridium perfringens; Disease Models, Animal; Gas Gangrene; Imipenem; Mice; Microbial Sensitivity Tests; Penicillin G; Rifampin | 1988 |
The effect of anaerobiosis on antistaphylococcal antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin | 1988 |
In-vitro activity of fleroxacin against Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Fleroxacin; Microbial Sensitivity Tests; Tetracyclines | 1988 |
In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefoxitin; Ciprofloxacin; Clindamycin; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests | 1987 |
Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits.
Topics: Animals; Anti-Bacterial Agents; Catheterization; Catheters, Indwelling; Chlorhexidine; Ciprofloxacin; Clindamycin; Dicloxacillin; Fusidic Acid; Half-Life; Rabbits; Staphylococcal Infections | 1993 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
[Ciprofloxacin as a cause of a behavior disorder in a patient admitted into intensive care].
Topics: Adult; Ciprofloxacin; Clindamycin; Critical Care; Delirium; Drug Therapy, Combination; Hallucinations; Humans; Male; Shock, Septic; Tremor | 1994 |
Streptococcus sanguis bacteremia during ciprofloxacin therapy of a diabetic foot ulcer.
Topics: Bacteremia; Ciprofloxacin; Clindamycin; Diabetes Mellitus, Type 1; Diabetic Foot; Drug Resistance, Microbial; Humans; Male; Middle Aged; Streptococcal Infections; Streptococcus sanguis | 1994 |
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; beta-Lactamases; Cefoxitin; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1993 |
Primary sternal osteomyelitis.
Topics: Adult; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Debridement; Female; Humans; Osteomyelitis; Staphylococcal Infections; Sternum; Tomography, X-Ray Computed | 1993 |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
Topics: Animals; Antimalarials; Azithromycin; Babesiosis; Ciprofloxacin; Clindamycin; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Mesocricetus; Organometallic Compounds; Quinine; Spiro Compounds; Survival Analysis | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
Epileptogenic effect of antibiotic drugs.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Clindamycin; Electroencephalography; Epilepsy; Erythromycin; Hippocampus; Humans; In Vitro Techniques; Penicillins; Rats; Rats, Wistar; Vancomycin | 1993 |
The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
Topics: Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Clindamycin; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Philadelphia; Rifampin; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1995 |
Isolation and antimicrobial susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy cows with retained fetal membranes and postparturient endometritis.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Cattle; Cattle Diseases; Ciprofloxacin; Clindamycin; Endometritis; Female; Metronidazole; Placenta, Retained; Pregnancy; Puerperal Infection; Tetracycline; Uterus | 1996 |
Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Ciprofloxacin; Clindamycin; Common Variable Immunodeficiency; Diagnosis, Differential; Female; Humans; Mycoplasma hominis; Mycoplasma Infections | 1996 |
The utility of non-beta-lactam antimicrobial MICs as markers to distinguish oxacillin-resistant from oxacillin-susceptible strains of Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Biomarkers; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcus epidermidis; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Imipenem; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1996 |
Severe knee arthritis due to Eikenella corrodens following a human bite.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Bites, Human; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Eikenella corrodens; Gram-Negative Bacterial Infections; Humans; Knee; Male; Microbial Sensitivity Tests; Penicillins | 1997 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Erythromycin; Fluoroquinolones; Gram-Positive Bacteria; Lactams; Microbial Sensitivity Tests; Naphthyridines; Vancomycin | 1997 |
Influence of low dose ciprofloxacin on microbial colonization of the digestive tract in healthy volunteers during normal and during impaired colonization resistance.
Topics: Adolescent; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Candida; Ciprofloxacin; Clindamycin; Digestive System; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Negative Bacteria; Humans; Male | 1997 |
In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Erythromycin; Fluoroquinolones; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma hominis; Mycoplasma pneumoniae; Naphthyridines; Quinolones; Tetracycline; Ureaplasma urealyticum | 1997 |
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
A plastid organelle as a drug target in apicomplexan parasites.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chloramphenicol; Ciprofloxacin; Clindamycin; Coccidiostats; DNA Replication; Gene Dosage; Humans; Plastids; Topoisomerase II Inhibitors; Toxoplasma | 1997 |
Periapical abscesses: causal bacteria and antibiotic sensitivity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxalactam; Pefloxacin; Periapical Abscess | 1997 |
In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clindamycin; Cross Infection; Drug Resistance, Microbial; Glycopeptides; Humans; Italy; Oxacillin; Penicillins; Rifampin; Serum Bactericidal Test; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Cell Line; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fibroblasts; Genetic Engineering; Humans; Listeria monocytogenes; Mice; Rifampin; Virginiamycin | 1998 |
Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Cecum; Ciprofloxacin; Clindamycin; Cytokines; Drug Therapy, Combination; Gentamicins; Imipenem; Interleukin-1; Interleukin-6; Lung; Mice; Mice, Inbred BALB C; Morbidity; Neutrophils; Peroxidase; Sepsis; Survival Rate; Tumor Necrosis Factor-alpha | 1998 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella | 1998 |
Antibiotics and light responses in superfused bovine retina.
Topics: Animals; Anti-Bacterial Agents; Cattle; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Electroretinography; In Vitro Techniques; Light; Perfusion; Retina | 1999 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Glycopeptides; Imipenem; Inhibitory Concentration 50; Microbial Sensitivity Tests; Penicillins; Streptococcus | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; Genital Diseases, Male; Humans; Male; Ofloxacin; Pelvic Inflammatory Disease; Peritonitis; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases | 1999 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Adhesion; Ciprofloxacin; Clindamycin; Conjunctiva; Endophthalmitis; Epithelial Cells; Gentamicins; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microbial Sensitivity Tests; Postoperative Complications; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2001 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bioterrorism; Blood; Ciprofloxacin; Clindamycin; District of Columbia; Dyspnea; Fever; Humans; Lymphatic Diseases; Male; Mediastinal Diseases; Middle Aged; Occupational Exposure; Pleural Effusion; Polymerase Chain Reaction; Postal Service; Radiography, Thoracic; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survivors; Tomography, X-Ray Computed | 2001 |
Anthrax. A 'sure killer' yields to medicine.
Topics: Adult; Anthrax; Bacillus anthracis; Child; Ciprofloxacin; Clindamycin; Disease Susceptibility; Drug Therapy, Combination; Female; History, 20th Century; History, 21st Century; Humans; Male; Pleural Effusion; Prognosis; Rifampin; Russia; United States | 2001 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
In-vitro activity of ciprofloxacin combined with flomoxef against Bacteroides fragilis, compared with that of ciprofloxacin combined with clindamycin.
Topics: Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests | 2002 |
Anaerobic infection of the lumbar spine in an intravenous drug abuser.
Topics: Adult; Anaerobiosis; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Epidural Abscess; Female; Humans; Metronidazole; Spine; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous | 2002 |
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
Topics: Anaerobiosis; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; beta-Lactams; Ciprofloxacin; Clindamycin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2002 |
Septic arthritis caused by Erysipelothrix rhusiopathiae infection after arthroscopically assisted anterior cruciate ligament reconstruction.
Topics: Adolescent; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Arthritis, Infectious; Arthroscopy; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Erysipelothrix; Erysipelothrix Infections; Humans; Knee Injuries; Lacerations; Male; Penicillins; Recurrence; Rupture; Soccer; Surgical Wound Infection; Synovial Fluid; Teicoplanin; Therapeutic Irrigation | 2003 |
Treatment of post-traumatic tibial osteomyelitis using microsurgical flaps.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bone Transplantation; Child; Ciprofloxacin; Clindamycin; Debridement; External Fixators; Female; Humans; Male; Microsurgery; Middle Aged; Muscle, Skeletal; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps; Tibia; Treatment Outcome | 2003 |
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Campylobacter jejuni; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Germany; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Tetracycline | 2003 |
[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cecum; Ciprofloxacin; Clindamycin; Colony-Forming Units Assay; Cytokines; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Female; Gram-Negative Bacteria; Imipenem; Inflammation; Interleukin-10; Interleukin-6; Leukocytes; Lipopolysaccharides; Male; Mice; Sepsis; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma hominis; Quinolines; Sampling Studies; Sensitivity and Specificity; Singapore; Tetracycline | 2004 |
Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Biofilms; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Netilmicin; Predictive Value of Tests; Pseudomonas aeruginosa; Staphylococcus; Teicoplanin; Tetracycline; Vancomycin | 2004 |
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriocins; Chloramphenicol; Ciprofloxacin; Clindamycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Hospitals, Pediatric; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Plasmids; Poland; Staphylococcus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Mediastinitis caused by an infected mandibular cyst.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dentigerous Cyst; Drainage; Focal Infection, Dental; Humans; Male; Mandibular Diseases; Mediastinitis; Middle Aged | 2004 |
Spondylitis following vertebroplasty: a case report.
Topics: Administration, Oral; Cervical Vertebrae; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fracture Fixation; Humans; Infusions, Intravenous; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Male; Middle Aged; Osteoporosis; Spinal Fractures; Spondylitis | 2005 |
Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Topics: Administration, Oral; Animals; Anthrax; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Blood; Ciprofloxacin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Gamma Rays; Injections, Subcutaneous; Liver; Lung; Mice; Moxifloxacin; Quinolines; Radiation Injuries, Experimental; Survival Analysis | 2005 |
Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges.
Topics: Anti-Bacterial Agents; Caffeine; Chromatography, Liquid; Ciprofloxacin; Clindamycin; Environmental Monitoring; Spectrum Analysis; Sulfamethoxazole; Tetracycline; Trimethoprim; Waste Disposal, Fluid; Water Movements; Water Pollutants, Chemical; Water Pollution; Water Purification | 2006 |
A rare cause of sepsis in an 18 year old. Lemierre's syndrome with external jugular vein thrombosis.
Topics: Adolescent; Anti-Infective Agents; Body Piercing; Ciprofloxacin; Clindamycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Fever; Humans; Jugular Veins; Lip; Pharyngitis; Sepsis; Syndrome; Tonsillitis; Urticaria; Venous Thrombosis | 2006 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
[Otitis externa: which antibiotics are first choice?].
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Humans; Methicillin; Ofloxacin; Ointments; Otitis Externa; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
The effects of anti-bacterials on the malaria parasite Plasmodium falciparum.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Clindamycin; DNA Replication; Malaria, Falciparum; Plasmodium falciparum; Protein Biosynthesis; Rifampin; Tetracycline; Thiostrepton; Time Factors; Transcription, Genetic | 2007 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection | 2006 |
Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Infant; Lymphadenitis; Male; Methicillin Resistance; Neck; Oxacillin; Penicillin Resistance; Pharyngeal Diseases; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Prevalence and antimicrobial resistance of Campylobacter in US dairy cattle.
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Cattle Diseases; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Nalidixic Acid; Prevalence; Tetracycline; United States | 2007 |
Devastating femoral osteomyelitis after anterior cruciate ligament reconstruction.
Topics: Adult; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Anti-Infective Agents; Arthritis, Infectious; Bone-Patellar Tendon-Bone Grafting; Ciprofloxacin; Clindamycin; Debridement; Female; Femur; Humans; Knee Prosthesis; Limb Salvage; Osteomyelitis; Reoperation; Surgical Wound Infection | 2008 |
Salmonella gas-forming femoral osteomyelitis and pyomyositis: the first case and review of the literature.
Topics: Acinetobacter Infections; Ceftriaxone; Ciprofloxacin; Clindamycin; Cross Infection; Fatal Outcome; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Osteomyelitis; Pyomyositis; Salmonella Infections | 2007 |
Our experience using primary oral antibiotics in the management of orbital cellulitis in a tertiary referral centre.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Infant; Injections, Intravenous; Middle Aged; Orbital Cellulitis; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
One-stage revision of infected total hip arthroplasty with bone graft.
Topics: Acetabulum; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Transplantation; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Female; Femur; Follow-Up Studies; Hip Joint; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prosthesis-Related Infections; Radiography; Reoperation; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Treatment Outcome | 2008 |
[Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteria; beta-Lactamases; Cephalosporin Resistance; Cephalothin; Child; Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nucleic Acid Synthesis Inhibitors; Shigella sonnei; Staphylococcus aureus | 2008 |
Toxoplasma gondii: a simple Real-time PCR assay to quantify the proliferation of the apicoplast.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clindamycin; Computer Systems; DNA, Protozoan; Electrophoresis, Agar Gel; HeLa Cells; Humans; Plastids; Polymerase Chain Reaction; Toxoplasma | 2009 |
[Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Naphthyridines | 2010 |
Hospital-acquired pneumonia and bacteremia caused by Legionella pneumophila in an immunocompromised patient.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Ciprofloxacin; Clindamycin; Cross Infection; Female; Hospitals; Humans; Immunocompromised Host; Immunosuppressive Agents; Legionella pneumophila; Legionnaires' Disease; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Steroids; Taiwan | 2010 |
Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Aryldialkylphosphatase; Ciprofloxacin; Clindamycin; Hep G2 Cells; Hepatocytes; Humans; Kinetics; Osmolar Concentration; Rifamycins | 2010 |
[Activity of daptomycin, ciprofloxacin, clindamycin and cotrimoxazole against coagulase-negative Staphylococcus strains with diminished susceptibility to vancomycin].
Topics: Ciprofloxacin; Clindamycin; Coagulase; Daptomycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin Resistance | 2010 |
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age].
Topics: Aza Compounds; Ciprofloxacin; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Gatifloxacin; Genotype; Humans; Infant; Infant, Newborn; Male; Metronidazole; Moxifloxacin; Phenotype; Quinolines; Species Specificity; Vancomycin | 2010 |
Synergism between outer membrane proteins and antimicrobials.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefotaxime; Chlorocebus aethiops; Ciprofloxacin; Clindamycin; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Tetracycline; Vero Cells | 2011 |
Antimicrobial resistance in Campylobacter coli isolated from pigs in two provinces of China.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Campylobacter coli; China; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests; Swine; Swine Diseases; Tetracycline | 2011 |
Changes in antibiotic distribution due to pancreatitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Male; Meropenem; Organotin Compounds; Pancreatitis; Piperacillin; Rats; Rats, Wistar; Thienamycins | 2011 |
Use of gentamicin collagen sponges for the treatment of periprosthetic breast implant infection.
Topics: Adult; Anti-Bacterial Agents; Breast Implants; Ciprofloxacin; Clindamycin; Collagen; Combined Modality Therapy; Female; Freeze Drying; Gentamicins; Humans; Middle Aged; Prosthesis Design; Prosthesis-Related Infections; Surgical Sponges | 2011 |
Fulminant spread of a femur anaerobic osteomyelitis to abdomen in a 17-year-old boy.
Topics: Abdominal Cavity; Adolescent; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides; Ciprofloxacin; Clindamycin; Debridement; Femur; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Osteomyelitis; Radiography; Treatment Outcome | 2012 |
Incidence and antimicrobial resistance profiling of Campylobacter in retail chicken livers and gizzards.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Chloramphenicol; Ciprofloxacin; Clindamycin; Colony Count, Microbial; DNA, Bacterial; Doxycycline; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Gizzard, Avian; Incidence; Liver; Meat Products; Microbial Sensitivity Tests; Nalidixic Acid; Oklahoma; Tetracycline | 2012 |
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lithuania; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Tetracycline | 2013 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Antibiotic resistance in human peri-implantitis microbiota.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biofilms; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Microbial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peri-Implantitis; Retrospective Studies | 2014 |
Antibiotic resistance in human chronic periodontitis microbiota.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Candida; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Fusobacterium nucleatum; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Prevotella intermedia; Prevotella nigrescens; Staphylococcus aureus; Streptococcus constellatus | 2014 |
Sacro-iliac osteomyelitis in a 13 year old boy following perforated appendicitis.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ascitic Fluid; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Humans; Laparotomy; Magnetic Resonance Imaging; Male; Metronidazole; Osteomyelitis; Rifampin; Rupture, Spontaneous; Sacroiliitis | 2013 |
A rare case of Meleney's ulcer after partial chemical matricectomy.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Fasciitis, Necrotizing; Female; Gangrene; Humans; Nails; Skin Ulcer; Surgical Wound Infection; Toes | 2013 |
Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system.
Topics: Adolescent; Afghan Campaign 2001-; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Clindamycin; Humans; Male; Military Personnel; Polymerase Chain Reaction; Skin Diseases, Bacterial | 2013 |
Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Child; Child, Preschool; Ciprofloxacin; Clindamycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Exotoxins; Gentamicins; Humans; Infant; Iran; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Micrococcal Nuclease; Middle Aged; Oxazolidinones; Penicillin-Binding Proteins; Phenotype; Prevalence; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2014 |
Lower extremities and iliopsoas pyomyositis with concurrent septic arthritis and spinal epidural abscess in a diabetic patient.
Topics: Arthritis, Infectious; Benzoyl Peroxide; Ciprofloxacin; Clindamycin; Drug Combinations; Epidural Abscess; Humans; Magnetic Resonance Imaging; Male; Pyomyositis; Staphylococcal Infections; Thigh; Vancomycin | 2013 |
Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?
Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clindamycin; Cohort Studies; Diabetic Foot; Female; Humans; Male; Middle Aged; Retrospective Studies; Wound Healing | 2014 |
Following the mechanisms of bacteriostatic versus bactericidal action using Raman spectroscopy.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; DNA, Bacterial; Microbial Sensitivity Tests; Spectrum Analysis, Raman; Staphylococcus epidermidis | 2013 |
Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Staphylococcal Infections; Staphylococcus epidermidis; United States | 2014 |
Comparison of Sensititre microdilution method to other standard methods for susceptibility testing of coagulase-negative staphylococci from paediatric blood cultures.
Topics: Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clindamycin; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus epidermidis; Staphylococcus hominis; Tetracycline; Vancomycin | 2014 |
Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth.
Topics: Actinomyces; Actinomyces viscosus; Amoxicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Dental Pulp Diseases; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Limosilactobacillus fermentum; Moxifloxacin; Penicillin G; Penicillin Resistance; Prevotella; Propionibacterium; Rifampin; Streptococcus mutans; Tetracycline Resistance; Tooth, Nonvital; Vancomycin Resistance | 2014 |
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Topics: Amdinocillin; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Clindamycin; Dicloxacillin; Escherichia coli; Gram-Positive Bacteria; Meropenem; Mice; Penicillins; Thienamycins | 2014 |
Antibiotic susceptibility of periodontal Streptococcus constellatus and Streptococcus intermedius clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Streptococcus; Streptococcus intermedius; Tetracycline Resistance | 2014 |
Vasitis: the need for imaging and clinical acumen.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Diagnosis, Differential; Follow-Up Studies; Genital Diseases, Male; Gentamicins; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Scrotum; Spermatic Cord; Systemic Inflammatory Response Syndrome; Ultrasonography; Vas Deferens | 2014 |
Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Hospitals, University; Humans; Microbial Sensitivity Tests; Switzerland | 2014 |
Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin.
Topics: Bacteria, Anaerobic; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Healthy Volunteers; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Microbiota; Nasal Cavity; Oropharynx; Placebos; Skin; Time Factors | 2015 |
Effects of two combinations of triple antibiotic paste used in endodontic regeneration on root microhardness and chemical structure of radicular dentine.
Topics: Anti-Bacterial Agents; Apexification; Ciprofloxacin; Clindamycin; Dental Pulp; Dental Pulp Cavity; Dentin; Hardness; Humans; Materials Testing; Metronidazole; Microscopy, Electron, Scanning; Minocycline; Random Allocation; Regeneration; Root Canal Irrigants; Spectroscopy, Fourier Transform Infrared | 2014 |
Effects of antibiotic treatment on the lactobacillus composition of vaginal microbiota.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Erythromycin; Female; Gentamicins; Humans; Lactobacillus; Microbial Sensitivity Tests; Microbiota; Pregnancy; Tetracycline; Vagina | 2015 |
Epidemiology of antimicrobial resistance in an oncology center in eastern India.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts | 2015 |
Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Load; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colony Count, Microbial; Feces; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Healthy Volunteers; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Placebos; RNA, Ribosomal, 16S; Time Factors; Young Adult | 2015 |
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Feces; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Healthy Volunteers; Humans; Microbiota; Saliva | 2015 |
Survey of community-associated-methicillin-Resistant Staphylococcus aureus in Slovenia: identification of community-associated and livestock-associated clones.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Clindamycin; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Erythromycin; Exotoxins; Gentamicins; Leukocidins; Livestock; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Penicillin-Binding Proteins; Slovenia | 2015 |
Clostridium difficile infection in rural Ontario: a retrospective multisite population-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catchment Area, Health; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Nursing Homes; Ontario; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Rural Population; Young Adult | 2015 |
Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Cross Infection; Doxycycline; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Joint Prosthesis; Linezolid; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2015 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia.
Topics: Anaerobiospirillum; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Delayed Diagnosis; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pelvis; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
A case report of inhalation anthrax acquired naturally.
Topics: Aged; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Clindamycin; Fatal Outcome; Humans; Jaundice; Male; Penicillins; Respiratory Tract Infections; Sepsis; Treatment Failure; Zoonoses | 2016 |
Eosinophilic pneumonia: Daptomycin-induced lung complication.
Topics: Abscess; Amputation Stumps; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Daptomycin; Debridement; Diabetic Foot; Drainage; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Pulmonary Eosinophilia; Soft Tissue Infections; Surgical Wound Infection; Tomography, X-Ray Computed | 2016 |
Growth Behavior of E. coli, Enterococcus and Staphylococcus Species in the Presence and Absence of Sub-inhibitory Antibiotic Concentrations: Consequences for Interpretation of Culture-Based Data.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drinking Water; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sewage; Sulfamethoxazole; Trimethoprim; Vancomycin-Resistant Enterococci; Water Microbiology | 2016 |
Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case report.
Topics: Adult; Bacteremia; Ceftriaxone; Ciprofloxacin; Clindamycin; Coinfection; Edwardsiella tarda; Enterobacteriaceae Infections; Humans; Male; Methicillin; Near Drowning; Oxacillin; Pneumonia; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Penicillins; Pneumococcal Infections; RNA, Ribosomal, 23S; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Clindamycin; Coinfection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Male; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Antimicrobial Resistance of Campylobacter Species Isolated from Broilers in Live Bird Markets in Shanghai, China.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Campylobacter coli; Campylobacter jejuni; Carrier Proteins; Chickens; China; Ciprofloxacin; Clindamycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Erythromycin; Food Contamination; Food Microbiology; Gentamicins; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Poultry; Quinolones; RNA, Ribosomal, 23S; Tetracyclines | 2017 |
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin | 2017 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Deoxyribonuclease I; Gentamicins; Humans; Hydrogen Peroxide; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Soaps; Staphylococcus aureus; Vancomycin | 2017 |
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Farmers; Female; Gentamicins; Humans; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Swine; Swine Diseases; Taiwan; Tigecycline; Virginiamycin | 2018 |
Clindamycin-modified Triple Antibiotic Nanofibers: A Stain-free Antimicrobial Intracanal Drug Delivery System.
Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Clindamycin; Dental Pulp; Drug Delivery Systems; Drug Therapy, Combination; Humans; Metronidazole; Nanofibers | 2018 |
Treating Anthrax-Induced Meningitis in Rabbits.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Antitoxins; Bacillus anthracis; Central Nervous System; Ciprofloxacin; Clindamycin; Dexamethasone; Disease Models, Animal; Drug Combinations; Imipenem; Levofloxacin; Linezolid; Meningitis, Bacterial; Meropenem; Rabbits; Treatment Failure | 2018 |
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Rhodospirillaceae; Stenotrophomonas maltophilia; Virulence | 2018 |
Revascularization in Immature and Mature Teeth with Necrotic Pulp: A Clinical Study.
Topics: Adolescent; Adult; Aluminum Compounds; Anti-Bacterial Agents; Calcium Compounds; Child; Ciprofloxacin; Clindamycin; Dental Pulp Necrosis; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Oxides; Regenerative Endodontics; Root Canal Filling Materials; Root Canal Therapy; Silicates; Thrombosis; Time Factors; Tooth Apex; Young Adult | 2018 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genotype; Gentamicins; Humans; Latvia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Poultry; Prevalence; Sentinel Surveillance; Swine; Tetracyclines; Whole Genome Sequencing | 2019 |
Successional Dynamics in the Gut Microbiome Determine the Success of
Topics: Animals; Anti-Bacterial Agents; Bacterial Shedding; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Gastrointestinal Microbiome; Microbial Interactions; Swine | 2019 |
Topics: Anti-Bacterial Agents; Caco-2 Cells; Cell Line, Tumor; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; HT29 Cells; Humans; Mucous Membrane; Risk Factors; Tigecycline; Tight Junctions | 2020 |
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Biomarkers; Ciprofloxacin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Macaca mulatta; Prognosis; Respiratory Tract Infections; Treatment Outcome | 2021 |
CE-DAD-MS/MS in the simultaneous determination and identification of selected antibiotic drugs and their metabolites in human urine samples.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Clindamycin; Electrophoresis, Capillary; Humans; Linezolid; Metronidazole; Tandem Mass Spectrometry | 2022 |
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Doxycycline; Gentamicins; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Silver; Staphylococcus aureus; Tobramycin | 2022 |
Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Humans; Macrolides; Propionibacteriaceae | 2022 |
The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
Topics: Adult; Anti-Bacterial Agents; Bacteriology; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hidradenitis Suppurativa; Humans; Referral and Consultation; Rifampin; Sulfamethoxazole; Trimethoprim | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2022 |
Analysis of the Antimicrobial and Anti-Biofilm Activity of Natural Compounds and Their Analogues against
Topics: Aldehydes; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Eugenol; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptomycin | 2022 |
Short term ciprofloxacin and clindamycin combination antibiotic therapy before and after transrectal ultrasound scan and prostate biopsy: Its impact on major components of gut microbiome.
Topics: Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clindamycin; Gastrointestinal Microbiome; Humans; Male; Prostate | 2022 |
Antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii isolated from patients with mastadenitis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Capnocytophaga; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Fusobacterium; Humans; Leptothrix; Leptotrichia; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases | 2023 |
Detection of Genes Encoding Microbial Surface Component Recognizing Adhesive Matrix Molecules in Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Ceftaroline; Chloramphenicol; Ciprofloxacin; Clindamycin; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pyoderma; Rifampin; Staphylococcus aureus | 2023 |
Oral antimicrobial agents in patients with short bowel syndrome: worth a try!
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Female; Floxacillin; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Short Bowel Syndrome | 2023 |
Arterial leg ulcers-Bacterial patterns, antimicrobial resistance and clinical characteristics, a retrospective single-centre cohort, 2012-2021.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Escherichia coli; Humans; Leg Ulcer; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |